NEXT Oncology Expands to Japan in Joint Venture Partnership With Kansai Medical University
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Business Wire
With continued global expansion, NEXT Oncology is one of the world’s largest Phase I Cancer Trial organizations. SAN ANTONIO--(BUSINESS WIRE)--NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medical University in Osaka, Japan. Under the guidance of Dr. Toshio Shimizu as the Director of the Phase I program, Kansai Medical University will now offer patients in Japan the opportunity to participate in Phase I clinical trials as part of the global NEXT Oncology network.Dr. Shimizu is a Professor in the Department of New Experimental Therapeutics and Director of Early Phase I Drug Development Services at the Kansai Medical University Hospital, Osaka, Japan. Under the leadership and mentorship of NEXT Oncology’s CEO and Founder Dr. Anthony W. Tolcher, he completed an advanced clinical fellowship in early Phase I drug development in San Antonio from 2010 to 2012. Prof. Shimizu previously engaged in numerous oncology Phase I
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform [Yahoo! Finance]Yahoo! Finance
- IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI PlatformBusiness Wire
- IQVIA (NYSE:IQV) was given a new $265.00 price target on by analysts at Morgan Stanley.MarketBeat
- IQVIA (NYSE:IQV) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IQV&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from a "MarketBeat
- ODAIA Adds Senior Pharma and AI Leaders to Accelerate Growth and Industry Adoption [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 11/14/25 - Form 3
- 11/7/25 - Form 4
- 11/7/25 - Form 4
- IQV's page on the SEC website